Abstract
The stability of the complex between IgE and its high-affinity receptor, FcɛRI, on mast cells is a critical factor in the allergic response. The long half-life of the complex of IgE bound to this receptor in situ (∼2 weeks, compared with only hours for the comparable IgG complex) contributes to the permanent sensitization of these cells and, hence, to the immediate response to allergens. Here we show that the second constant domain of IgE, Cɛ2, which takes the place of the flexible hinge in IgG, contributes to this long half-life. When the Cɛ2 domain is deleted from the IgE Fc fragment, leaving only the Cɛ3 and Cɛ4 domains (Cɛ3–4 fragment), the rate of dissociation from the receptor is increased by greater than 1 order of magnitude. We report the structure of the Cɛ2 domain by heteronuclear NMR spectroscopy and show by chemical shift perturbation that it interacts with FcɛRIα. By sedimentation equilibrium we show that the Cɛ2 domain binds to the Cɛ3–4 fragment of IgE. These interactions of Cɛ2 with both FcɛRIα and Cɛ3–4 provide a structural explanation for the exceptionally slow dissociation of the IgE–FcɛRIα complex.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Metzger, H. Curr. Opin. Immunol. 3, 40–46 (1991).
Ravetch, J.V. & Kinet, J.P. Annu. Rev. Immunol. 9, 457–492 (1991).
Metzger, H. et al. Annu. Rev. Immunol. 4, 419–470 (1986).
Geha, R.S., Helm, B. & Gould, H. Nature 315, 577–578 (1985).
Garman, S.C., Wurzburg, B.A., Tarchevskaya, S.S., Kinet, J.P. & Jardetzky, T.S. Nature 406, 259–266 (2000).
Sondermann, P., Huber, R., Oosthuizen, V. & Jacob, U. Nature 406, 267–273 (2000).
Henry, A.J. et al. Biochemistry 36, 15568–15578 (1997).
Shi, J. et al. Biochemistry 36, 2112–2122 (1997).
Dorrington, K.J. & Bennich, H.H. Immunol. Rev. 41, 3–25 (1978).
Ghirlando, R. et al. Biochemistry 34, 13320–13327 (1995).
Beavil, A.J., Young, R.J., Sutton, B.J. & Perkins, S.J. Biochemistry 34, 14449–14461 (1995).
Zheng, Y., Shopes, B., Holowka, D. & Baird, B. Biochemistry 31, 7446–7456 (1992).
Wurzburg, B.A., Garman, S.C. & Jardetzky, T.S. Immunity 13, 375–385 (2000).
Henry, A.J., McDonnell, J.M., Ghirlando, R., Sutton, B.J. & Gould, H.J. Biochemistry 39, 7406–7413 (2000).
McDonnell, J.M. et al. J. Mol. Biol. 279, 921–928 (1998).
Takatsu, K., Ishizaka, T. & Ishizaka, K. J. Immunol. 114, 1838–1845 (1975).
Padlan, E.A. & Helm, B.A. Receptor 2, 129–144 (1992).
Holm, L. & Sander, C. J. Mol. Biol. 233, 123–138 (1993).
Helm, B.A., Ling, Y., Teale, C., Padlan, E.A. & Bruggemann, M. Eur. J. Immunol. 21, 1543–1548 (1991).
Fridriksson, E.K. et al. Biochemistry 39, 3369–3376 (2000).
Güntert, P., Mumenthaler, C. & Wüthrich, K. J. Mol. Biol. 273, 283–298 (1997).
Hulett, M.D., Brinkworth, R.I., McKenzie, I.F. & Hogarth, P.M. J. Biol. Chem. 274, 13345–13352 (1999).
Cook, J.P. et al. Biochemistry 36, 15579–15588 (1997).
Kenten, J.H. et al. Proc. Natl. Acad. Sci. USA 79, 6661–6665 (1982).
Bohmann, D. & Tjian, R. Cell 59, 709–717 (1989).
Taylor, M.A. et al. Protein Eng. 5, 455–459 (1992).
Young, R.J. et al. Protein Eng. 8, 193–199 (1995).
Perkins, S.J. Eur. J. Biochem. 157, 169–180 (1986).
Weast, R.C., Handbook of chemistry and physics. (CRC Press, Oxford; 1968).
McDonnell, J.M., Fushman, D., Milliman, C.L., Korsmeyer, S.J. & Cowburn, D. Cell 96, 625–634 (1999).
Clore, G.M., Bax, A., Driscoll, P.C., Wingfield, P.T. & Gronenborn, A.M. Biochemistry 29, 8172–8184 (1990).
Grzesiek, S. et al. Biochemistry 31, 8180–8190 (1992).
Grzesiek, S. & Bax, A. J. Biomol. NMR 3, 185–204 (1993).
Bagby, S., Harvey, T.S., Eagle, S.G., Inouye, S. & Ikura, M. Structure 2, 107–122 (1994).
Koradi, R., Billeter, M. & Wuthrich, K. J. Mol. Graph. 14, 51–55 (1996).
Laskowski, R.A., Rullman, J.A., MacArthur, M.W., Kaptein, R. & Thornton, J.M. J. Biomol. NMR 8, 477–486 (1996).
Acknowledgements
We are grateful to M. Werner for some of the pulse sequences used. Awards from the NIH, Pharmacia Allergy Research Foundation Fellowship, MRC and BBSRC (UK), The Wellcome Trust and National Asthma Campaign (UK) supported this work.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
McDonnell, J., Calvert, R., Beavil, R. et al. The structure of the IgE Cɛ2 domain and its role in stabilizing the complex with its high-affinity receptor FcɛRIα. Nat Struct Mol Biol 8, 437–441 (2001). https://doi.org/10.1038/87603
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/87603
This article is cited by
-
Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy
Clinical Reviews in Allergy & Immunology (2022)
-
Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy
Nature Communications (2022)
-
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
Nature Communications (2020)
-
NMR backbone assignment of the Cε4 domain of immunoglobulin E
Biomolecular NMR Assignments (2020)
-
The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells
Scientific Reports (2018)